Nor-epinephrine Versus Midodrine/Octreotide in Patients With Hepatorenal Syndrome
Status:
Completed
Trial end date:
2020-01-23
Target enrollment:
Participant gender:
Summary
Hepatorenal syndrome is a functional renal impairment occurring in cirrhotic patients . It
develops secondary to splanchnic arterial vasodilatation which decreases the effective blood
volume, activate the renin-angiotensin-aldosterone system, and stimulate of sympathetic
nervous system.This study aims to compare the efficacy of nor-epinephrine versus midodrine/
octreotide, together with intravenous albumin on renal functions of patients with hepatorenal
acute kidney injury.
Phase:
N/A
Details
Lead Sponsor:
National Hepatology & Tropical Medicine Research Institute